ANI Pharmaceuticals Corp (ANIP) - מקדם חוב לטווח ארוך להון

The ANI Pharmaceuticals ecosystem relies on the stable supply of hospitals and pharmacies through the flexible production of niche generics. This price chart illustrates the trend of the indicator, which currently stands at 1.01. Steady cash flow and high margins on orphan drugs guarantee profit reliability, while the expansion of specialized gels and fresh product lines create a powerful growth impulse.

Investors are assessing the resilience of ANI Pharmaceuticals (ANIP) by analyzing long-term leverage, which measures credit obligations exceeding one year relative to shareholders' equity. The trend in the long-term debt-to-equity ratio demonstrates how effectively the generics portfolio finances expansion without critical debt burdens, determining the balance between financial leverage and the issuer's solvency.